Gene · 10499
Papers3,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting. | Int J Mol Sci | 2023 | 36769263 | PubTator, text mining | PubMed |
| MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | Nat Commun | 2023 | 36754959 | PubTator, text mining | PubMed |
| Translocations and Gene Fusions in Sinonasal Malignancies. | Curr Oncol Rep | 2023 | 36753024 | PubTator, text mining | PubMed |
| 2,4-Di-tert-butylphenol Induces Adipogenesis in Human Mesenchymal Stem Cells by Activating Retinoid X Receptors. | Endocrinology | 2023 | 36750942 | PubTator, text mining | PubMed |
| Editorial: Mechanisms, thermodynamics and kinetics of ligand binding revealed from molecular simulations and machine learning. | Front Mol Biosci | 2023 | 36733435 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma. | Cancer Res Treat | 2023 | 36731460 | PubTator, text mining | PubMed |
| Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options. | Int J Mol Sci | 2023 | 36674874 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 36674820 | PubTator, text mining | PubMed |
| Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma. | Cancers (Basel) | 2023 | 36672397 | PubTator, text mining | PubMed |
| VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis. | Cell Rep | 2023 | 36656711 | PubTator, text mining | PubMed |
| NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases. | Hum Pathol | 2023 | 36646185 | PubTator, text mining | PubMed |
| African inclusion in prostate cancer genomic studies provides the first glimpses into addressing health disparities through tailored clinical care. | Clin Transl Med | 2023 | 36629046 | PubTator, text mining | PubMed |
| Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. | Hepatology | 2023 | 36626642 | PubTator, text mining | PubMed |
| Mineral Profile, Antioxidant, Anti-Inflammatory, Antibacterial, Anti-Urease and Anti-α-Amylase Activities of the Unripe Fruit Extracts of Pistacia atlantica. | Molecules | 2023 | 36615545 | PubTator, text mining | PubMed |
| Chromatin modifiers: A new class of pollutants with potential epigenetic effects revealed by in vitro assays and transcriptomic analyses. | Toxicology | 2023 | 36581016 | PubTator, text mining | PubMed |
| Mutation of two residues converts the ligand-binding domain of RXRα into a uniform monomer without impairing the binding of retinoic acid and cofactors. | Biochem Biophys Res Commun | 2023 | 36563628 | PubTator, text mining | PubMed |
| Expanding the Spectrum of Perioral Myogenic Tumors in Pediatric Patients: An SRF::NCOA2 Fused Perivascular Tumor of the Philtrum. | Pediatr Dev Pathol | 2023 | 36457254 | PubTator, text mining | PubMed |
| ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome. | Hum Mol Genet | 2023 | 36440975 | PubTator, text mining | PubMed |
| Next-generation retinoid X receptor agonists increase ATRA signaling in organotypic epithelium cultures and have distinct effects on receptor dynamics. | J Biol Chem | 2023 | 36436565 | PubTator, text mining | PubMed |
| Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening. | Mol Biol Rep | 2023 | 36436079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10499/papers?page=15